Merck Research Laboratories

Latest stories

22d
Business Wire
Merck to Participate at the Morgan Stanley Global Healthcare Conferenceannounced today that Kenneth C. Frazier, chairman and chief executive officer,
Merck to Participate at the Morgan Stanley Global Healthcare Conference
Business Wire / Posted 22 days ago
announced today that Kenneth C. Frazier, chairman and chief executive officer, and Dr. Roger M. Perlmutter, president, Merck Research Laboratories, are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York on... Read more
29d
MedCity News
Increased stroke risk prompts Merck to pull the plug on osteoporosis drugthe increased risk of stroke in our Phase 3 trial does not support further deve
Increased stroke risk prompts Merck to pull the plug on osteoporosis drug
MedCity News / Posted 29 days ago
the increased risk of stroke in our Phase 3 trial does not support further development,” said Roger Perlmutter, president, Merck Research Laboratories, in a statement. Odanacatib was meant to be a once-weekly oral drug that would inhibit the... Read more
29d
FOX Business
Merck Scraps Osteoporosis Drug Development On Increased Risk Of Strokeprofile for odanacatib does not support filing or further development," said Ro
Merck Scraps Osteoporosis Drug Development On Increased Risk Of Stroke
FOX Business / Posted 29 days ago
profile for odanacatib does not support filing or further development," said Roger M. Perlmutter, M.D., Ph.D., president, Merck Research Laboratories. An independent review of the drug confirmed an increased risk of stroke, the company said in a... Read more
29d
FOX Business
Merck Scraps Osteoporosis Drug Development On Increased Risk Of Strokeprofile for odanacatib does not support filing or further development," said Ro
Merck Scraps Osteoporosis Drug Development On Increased Risk Of Stroke
FOX Business / Posted 29 days ago
profile for odanacatib does not support filing or further development," said Roger M. Perlmutter, M.D., Ph.D., president, Merck Research Laboratories. An independent review of the drug confirmed an increased risk of stroke, the company said in a... Read more
29d
Business Wire
Merck Provides Update on Odanacatib Development Programprofile for odanacatib does not support filing or further development,” said Ro
Merck Provides Update on Odanacatib Development Program
Business Wire / Posted 29 days ago
profile for odanacatib does not support filing or further development,” said Roger M. Perlmutter, M.D., Ph.D., president, Merck Research Laboratories. “We are very thankful to the researchers and patients who participated in the odanacatib... Read more

People in this news